The DOI matches its Crossref record; 243 of the 243 references it cites were found in a registry or an index.
Evidence-based guidelines for management of attention-deficit/hyperactivity disorder in adolescents in transition to adult services and in adults: recommendations from the British Association for Psychopharmacology
Abstract
Attention-deficit/hyperactivity disorder (ADHD) is an established diagnosis in children, associated with a large body of evidence on the benefits of treatment. Adolescents with ADHD are now leaving children’s services often with no readily identifiable adult service to support them, which presents problems as local pharmacy regulations often preclude the prescription of stimulant drugs by general practitioners (GPs). In addition, adults with ADHD symptoms are now starting to present to primary care and psychiatry services requesting assessment and treatment. For these reasons, the British Association for Psychopharmacology (BAP) thought it timely to hold a consensus conference to review the body of evidence on childhood ADHD and the growing literature on ADHD in older age groups. Much of this initial guidance on managing ADHD in adolescents in transition and in adults is based on expert opinion derived from childhood evidence. We hope that, by the time these guidelines are updated, much evidence will be available to address the many directions for future research that are detailed here.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Recent national guidelines now recommend that ADHD should be recognised and appropriately treated throughout the lifespan [32-34].”
From European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD (2010) · cites this paper as [34]
In the citing paper
“Psychostimulant medications are associated with disrupted or disturbed sleep”
From Associations of sleep disturbance with ADHD: implications for treatment (2015) · cites this paper as Nutt et al. 2007
Citations
Cites
Attention Deficit Hyperactivity Disorder: A Handbook for Diagnosis and Treatment
Barkley, R. A., & Poillion, M. J. (1994) · Behavioral Disorders · doi:10.1177/019874299401900205 · Cited by 4,639
Kessler, R. C., Adler, L., Barkley, R., Biederman, J., Conners, C. K., Demler, O., Faraone, S. V., Greenhill, L. L., Howes, M. J., Secnik, K., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.4.716 · Cited by 3,886
A Children's Global Assessment Scale (CGAS)
Shaffer, D. (1983) · Archives of General Psychiatry · doi:10.1001/archpsyc.1983.01790100074010 · Cited by 3,716 · cited 2×
“Scales such as the Clinical Global Adjustment Scale (Shaffer et al., 1983), the ADHD checklists (Adler et al.”
MethodWillcutt, E. G., Doyle, A. E., Nigg, J. T., Faraone, S. V., & Pennington, B. F. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.02.006 · Cited by 3,568 · cited 2×
“…– e.g. delay aversion, executive motor inhibition, deficit in arousal/activation regulation) that may underpin symptoms and behaviours, with neurobiological changes (e.g. dysfunction in frontostriatal circuitry, reward systems and catecholamine function (Waldman, 2005; Willcutt et al., 2005)).”
BackgroundKESSLER, R. C., ADLER, L., AMES, M., DEMLER, O., FARAONE, S., HIRIPI, E., HOWES, M. J., JIN, R., SECNIK, K., SPENCER, T., et al. (2005) · Psychological Medicine · doi:10.1017/s0033291704002892 · Cited by 3,452 · cited 3×
“1, Adler et al., 2004; Kessler et al., 2005) is patient-rated while the ADHD Rating Scale (ADHDRS-IV-Inv, Adler et al., 2005b) is clinician administered with good reliability and moderate agreement between raters.”
BackgroundMethod(1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.12.1073 · Cited by 3,372
(1958) · Journal of the American Pharmaceutical Association (Scientific ed.) · doi:10.1002/jps.3030470133 · Cited by 2,489
Molecular genetics of attention-deficit/hyperactivity disorder
Faraone, S. V., Perlis, R. H., Doyle, A. E., Smoller, J. W., Goralnick, J. J., Holmgren, M. A., & Sklar, P. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.11.024 · Cited by 2,357 · cited 3×
“…double-blind placebo-controlled trials have confirmed the efficacy of atomoxetine in children and adolescents (Thomason and Michelson, 2004 Ib), and similar findings with an effect size of 0.35–0.4 have been reported from two trials in adults (Michelson et al., 2003; Faraone et al., 2005a Ib).”
BackgroundResultInfluentialFARAONE, S. V., BIEDERMAN, J., & MICK, E. (2006) · Psychological Medicine · doi:10.1017/s003329170500471x · Cited by 2,267 · cited 3×
“…double-blind placebo-controlled trials have confirmed the efficacy of atomoxetine in children and adolescents (Thomason and Michelson, 2004 Ib), and similar findings with an effect size of 0.35–0.4 have been reported from two trials in adults (Michelson et al., 2003; Faraone et al., 2005a Ib).”
BackgroundResultInfluentialAttention-Deficit Hyperactivity Disorder: A Handbook for Diagnosis and Treatment
SPRAFKIN, J., & CARLSON, G. A. (1992) · American Journal of Psychiatry · doi:10.1176/ajp.149.9.1266 · Cited by 1,900
Research works printed but not linked: 19
- Alsop M (2005) Equality in Justice, ADHD Across the Lifespan. Dorset ADHD Support Group, Weymouth (www.dorsetadhd.org.uk)
- American Psychiatric Association (2000) Diagnostic and Statistical Manual of Mental Disorders version IV text revision. American Psychiatric Association, Washington DC
- 10.1177/026988110001400101 · DOI · Paper page
- 10.1111/1469-7610.00452 · doi:10.1111/1469-7610.00452 · Paper page
- Biederman J , Spencer T J (2001) Psychopharmacology of adults with attention-deficit/hyperactivity disorder . Primary Psychiatry 11: 57-62
- Bloom B , Dey A N (2004) Summary health statistics for U.S. children: National Health Interview Survey . Vital Health Stat 10: 1-85
- Brassett-Grundy A , Butler N (2004a) Attention-Deficit/Hyperactivity Disorder: An overview and review of the literature relating to the correlates and lifecourse outcomes for males and females. Bedford Group for Lifecourse and Statistical Studies Occasional Paper: No. 1. Institute of Education, University of London
- Brassett-Grundy A , Butler N (2004b) Prevalence and Adult Outcomes of Attention-Deficit/Hyperactivity Disorder: Evidence from a 30-year prospective longitudinal study. Bedford Group for Lifecourse and Statistical Studies Occasional Paper: No. 2. Institute of Education, University of London
- Coghill D (2006) Making the most of scant resources. In Yule W (ed.), The ADHD Spectrum. ACAMH Occasional papers 24, ACAMH, London
- Conners C K , Erhardt D , Sparrow E , Conners M A (1998) CAARS Adult ADHD Rating Scales. Multi Health Systems Inc., New York
- Gadow K , Sprafkin J , Weiss M (1999) Adult Inventories-4. Available at: www.checkmateplus.com
- 10.1037/0003-066X.43.10.786 · doi:10.1037/0003-066x.43.10.786 · Paper page
- Ward M F , Wender P H , Reimherr F W (1993) The Wender Utah Rating Scale: an aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder . Am J Psychiatry 150: 885-890 .
- Weiss M D , Murray C (2004) Practice Guideline for the Assessment of ADHD in adults. Canadian ADHD Resource Alliance, Vancouver, Canada
- WHO (1992) The ICD-10 classification of mental and behavioural disorders. Geneva, Switzerland
- World Health Organization (1992) The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines. World Health Organization, Geneva
- Young S J , Gudjonsson G (submitted) Growing out of attention-deficit/hyperactivity disorder: the relationship between functioning and symptoms
- Young S J , Ross R R (2006) R&R2 for ADHD youth and adults. A handbook for teaching prosocial competence. Cognitive Centre of Canada, Ottawa (cogcen@canada.com)
- Young S J , Ross R R (in preparation) R&R2 for ADHD children. A handbook for teaching prosocial competence
Cited by
Kooij, S. J., Bejerot, S., Blackwell, A., Caci, H., Casas-Brugué, M., Carpentier, P. J., Edvinsson, D., Fayyad, J., Foeken, K., Fitzgerald, M., et al. (2010) · BMC Psychiatry · doi:10.1186/1471-244x-10-67 · Cited by 928
“now recommend that ADHD should be recognised and appropriately treated throughout the lifespan [32-34].”
Self-citationShaw, M., Hodgkins, P., Caci, H., Young, S., Kahle, J., Woods, A. G., & Arnold, L. E. (2012) · BMC Medicine · doi:10.1186/1741-7015-10-99 · Cited by 759
“Several of these organizations recognize a need for further study of the long-term consequences of ADHD and of its treatment [22,29,30,32,33].”
BackgroundSelf-citationUpdated European Consensus Statement on diagnosis and treatment of adult ADHD
Kooij, J. J. S., Bijlenga, D., Salerno, L., Jaeschke, R., Bitter, I., Balázs, J., Thome, J., Dom, G., Kasper, S., Nunes Filipe, C., et al. (2019) · European Psychiatry · doi:10.1016/j.eurpsy.2018.11.001 · Cited by 686
Self-citationLive fast, die young? A review on the developmental trajectories of ADHD across the lifespan
Franke, B., Michelini, G., Asherson, P., Banaschewski, T., Bilbow, A., Buitelaar, J. K., Cormand, B., Faraone, S. V., Ginsberg, Y., Haavik, J., et al. (2018) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2018.08.001 · Cited by 643
Self-citationWilson, S., Nutt, D., Alford, C., Argyropoulos, S., Baldwin, D., Bateson, A., Britton, T., Crowe, C., Dijk, D.-J., Espie, C., et al. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881110379307 · Cited by 634
Self-citation
Metadata
- Authors
- Nutt, D. J., Fone, K., Asherson, P., Bramble, D., Hill, P., Matthews, K., Morris, K. A., Santosh, P., Sonuga-Barke, E., Taylor, E., Weiss, M., & Young, S.
- Affiliations
- University of Bristol (GB)
- University of Nottingham (GB)
- King's College London (GB)
- Telford & Wrekin PCT, Shrewsbury, UK
- London, UK
- University of Dundee (GB)
- Institute of Psychiatry, London, UK
- University of Southampton (GB)
- University of British Columbia (CA)
- Bethlem Royal Hospital (GB)
- Corresponding author
- Nutt, D. J.
- ORCID
- Venue
- Journal of Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2007-01
- Volume
- 21
- Issue
- 1
- Pages
- 10-41
- ISSN
- 0269-8811 (ISSN-L)
- 1461-7285
- OpenAlex
- W2006463161
- Semantic Scholar
- 601bde001c8005e8fae1acf04b12ce0b33b7db90
- Cited by
- 259
- References
- 242
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 6 · 2023: 4 · 2022: 4 · 2021: 10 · 2020: 8 · 2019: 5 · 2018: 8 · 2017: 12 · 2016: 13 · 2015: 12 · 2014: 28 · 2013: 28 · 2012: 37
- FWCI
- 10.19
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Journal of Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Discovery Research Portal (University of Dundee) (publishedVersion)
- ePrints Soton (University of Southampton) (submittedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmaceutical studies and practices
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Adolescent and Pediatric Healthcare
- Keywords
- attention deficit hyperactivity disorder, adult ADHD, adolescents, transition to adult services, stimulant medication, psychopharmacological treatment, primary care, consensus recommendations
- MeSH terms
- Adolescent, Adult, Age Factors, Central Nervous System Stimulants, Attention Deficit Disorder with Hyperactivity, United Kingdom, Health Services Needs and Demand, Humans, Mental Health Services, Primary Health Care, Psychiatric Status Rating Scales, Comorbidity, Adolescent Health Services, Models, Organizational, Evidence-Based Medicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Evidence-based guidelines for management of attention-deficit/hyperactivity disorder in adolescents in transition to adult services and in adults: recommendations from the British Association for Psychopharmacology. https://app.cochat.ai/papers/10.1177/0269881106073219
- The paper
- Nutt, D. J., Fone, K., Asherson, P., Bramble, D., Hill, P., Matthews, K., Morris, K. A., Santosh, P., Sonuga-Barke, E., Taylor, E., Weiss, M., & Young, S. (2007). Evidence-based guidelines for management of attention-deficit/hyperactivity disorder in adolescents in transition to adult services and in adults: recommendations from the British Association for Psychopharmacology. Journal of Psychopharmacology. https://doi.org/10.1177/0269881106073219
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.